Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease.

Weintraub D, Mavandadi S, Mamikonyan E, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Nazem S, Ten Have TR, Stern MB.

Neurology. 2010 Aug 3;75(5):448-55. doi: 10.1212/WNL.0b013e3181ebdd79.

2.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C.

Mov Disord. 2011 Oct;26 Suppl 3:S42-80. doi: 10.1002/mds.23884. Review.

3.

Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.

Simpson D, Plosker GL.

Drugs. 2004;64(2):205-22. Review.

PMID:
14717619
4.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
5.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
6.

Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.

Dell'Agnello G, Zuddas A, Masi G, Curatolo P, Besana D, Rossi A.

CNS Drugs. 2009 Sep;23(9):739-53. doi: 10.2165/11314350-000000000-00000. Review.

PMID:
19689165
7.

Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.

Simpson D, Plosker GL.

CNS Drugs. 2004;18(6):397-401. Review.

PMID:
15089111
8.

Psychiatric issues in cognitive impairment.

Aarsland D, Taylor JP, Weintraub D.

Mov Disord. 2014 Apr 15;29(5):651-62. doi: 10.1002/mds.25873. Review.

9.

Parkinson disease and comorbid cerebrovascular disease.

Nanhoe-Mahabier W, de Laat KF, Visser JE, Zijlmans J, de Leeuw FE, Bloem BR.

Nat Rev Neurol. 2009 Oct;5(10):533-41. doi: 10.1038/nrneurol.2009.136. Review.

PMID:
19724249

Supplemental Content

Support Center